2025 Agenda

Wednesday, October 15

Time

Event

8:00 am – Lobby Level

Registration Opens

8:00 am – Ground Floor,
Event Hall South

One-to-One Meetings 

8:55 am – 2nd Floor

Welcome Back 

  • Sara Jane Demy, Founder & CEO, Demy-Colton

9:00 am – 2nd Floor

“Big Think" Plenary Session  

The New Policy Landscape: How it’s Benefiting the Sector

Moderator:

  • Yeji Jesse Lee, Senior Healthcare Reporter, Law360

Panel: 

  • Jennifer Hawks Bland, CEO, NewYorkBIO
  • Cartier Esham, CEO, Esham Strategies
  • Nancy Myers, CEO & Founder, Catalyst Healthcare Consulting 
  • Peter Rubin, Executive Director, No Patient Left Behind 

10:00 am – Ground Floor,
Event Hall South

One-to-One Meetings

10:00 am – 2nd Floor

Dialogue 4A 

AI: From Target and Lead Discovery to Clinical Trials and Personalized Medicine – Revolutionizing Drug Development 

Moderator:

  • Rachel Ravens, Co-Founder & Managing Partner, 46Health

Panel: 

  • Ahmet-Hamdi Çavuşoğlu, Senior Director, Merck Digital Sciences Studio
  • Vitalay Fomin, Co-Founder & CEO, Numenos
  • Maria Pineda, CEO & Co-Founder, Envisagenics 

11:00 am – 2nd Floor

Seed Pitch Doctor Presentations 

Moderator:

  • Jay Campbell, Life Sciences Executive, CBO, CFO, & Advisory Board Member 

Pitch Doctors:

  • Jessica Federer, Investor & Board Member, Angelini Ventures
  • Michael Langer, Co-Founder & Managing Partner, T.Rx Capital
  • Stacey Seltzer, Managing Partner & Founder, Pontiva Healthcare Partners

12:15 pm – Ground Floor,
Event Hall South

Lunch

1:15 pm – 2nd Floor

“Big Think” Plenary Session 

Venture Investment in Early-Stage Biopharma: Are We Seeing Signs of Recovery?

Moderator:

  • Kelliann Payne, Partner, Global Regulatory, Hogan Lovells

Panel:

  • Jessica Federer, Investor & Board Member, Angelini Ventures
  • Michael Langer, Co-Founder & Managing Partner, T.Rx Capital

2:15 pm – 2nd Floor

Closing “Big Think” Plenary Session 

Heard Around the Street: What’s Buzzing in Biopharma       

Moderator:  

  • Virginia Amman, CEO & Founder, ENTENTE Networks 

Panel:

  • Max Bayer, Pharma Reporter, Endpoints News
  • Yeji Jesse Lee, Senior Healthcare Reporter, Law360
  • Alex Philippidis, Senior Business Editor, Genetic Engineering & Biotechnology News (GEN)
  • Aayushi Pratap, Associate Editor, C&EN, American Chemical Society

Be a part of BioFuture

© 2024 BioFutureTM. All Rights Reserved

Produced by